Page last updated: 2024-11-03

riluzole and Dysarthria, Pseudobulbar

riluzole has been researched along with Dysarthria, Pseudobulbar in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scott, K1
Shannon, R1
Roche-Green, A1
Searcy, R1
Woolyhand, G1
Meeks, G1
Schuh, M1
Kraft, P1
Beck, M1
Grimm, A1
Wessig, C1
Reiners, K1
Toyka, KV1

Other Studies

2 other studies available for riluzole and Dysarthria, Pseudobulbar

ArticleYear
Pharmacologic Management Strategies in ALS #301.
    Journal of palliative medicine, 2016, Volume: 19, Issue:3

    Topics: Amyotrophic Lateral Sclerosis; Depression; Dyspnea; Guidelines as Topic; Humans; Muscle Spasticity;

2016
[Amyotrophic lateral sclerosis: management of bulbar symptoms].
    Der Nervenarzt, 2010, Volume: 81, Issue:10

    Topics: Affective Symptoms; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Combined Modality Therapy;

2010